These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6244818)

  • 21. Purification and initial characterization of human placental trophoblast interferon induced by polyriboinosinic.polyribocytidylic acid.
    Aboagye-Mathiesen G; Tóth FD; Juhl C; Nørskov-Lauritsen N; Petersen PM; Ebbesen P
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():3061-6. PubMed ID: 1703216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the priming effect of interferon in L cells. I. The primed interferon response and the kinetics of development of priming.
    Rosztóczy I
    Acta Virol; 1976 Dec; 20(6):472-8. PubMed ID: 13642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of interferon in human lymphoblastoid cells by Sendai and measles viruses.
    Volckaert-Vervliet G; Billiau A
    J Gen Virol; 1977 Oct; 37(1):199-203. PubMed ID: 199704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing production of interferon by human lymphoblastoid cells.
    Johnston MD; Fantes KH; Finter NB
    Adv Exp Med Biol; 1978; 110():61-74. PubMed ID: 215014
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship of cytotoxicity and interferon-inducing activity of polyriboinosinic acid. Polyribocytidylic acid to the molecular weights of the homopolymers.
    Stewart WE; De Clercq E
    J Gen Virol; 1974 Apr; 23(1):83-9. PubMed ID: 4833602
    [No Abstract]   [Full Text] [Related]  

  • 26. Inducers of interferon inhibit the mitotic response of liver cells to partial hepatectomy.
    Jahiel RI; Taylor D; Rainford N; Hirschberg SE; Kroman R
    Proc Natl Acad Sci U S A; 1971 Apr; 68(4):740-2. PubMed ID: 5279515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):481-8. PubMed ID: 4371529
    [No Abstract]   [Full Text] [Related]  

  • 28. Polyriboinosinic-polyribocytidylic acid prevents chemically-induced malignant transformation in vitro.
    Marquardt H
    Nat New Biol; 1973 Dec; 246(155):228-9. PubMed ID: 4519609
    [No Abstract]   [Full Text] [Related]  

  • 29. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment.
    Emeny JM; Morgan MJ
    J Gen Virol; 1979 Apr; 43(1):253-5. PubMed ID: 113495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of interferon mRNA species from Sendai virus-induced human lymphoblastoid (Namalva) cells and Newcastle disease virus-induced murine fibroblastoid (L) cells.
    Sagar AD; Pickering LA; Sussman-Berger P; Stewart WE; Sehgal PB
    Nucleic Acids Res; 1981 Jan; 9(1):149-60. PubMed ID: 6163134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of interferon inducers on colony stimulating factor production in L cell cultures.
    Havredaki M; McNeill TA
    J Gen Virol; 1975 Apr; 27(1):107-10. PubMed ID: 1170275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic and metabolic studies on the priming effect of interferon in L cells.
    Rosztóczy I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):631-9. PubMed ID: 597012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon induction in human lymphocytes by complexes of vinyl copolymers with polynucleotides.
    Waschke K; Waschke SR; Hoffmann S; Witkowski W
    Acta Biol Med Ger; 1979; 38(5-6):739-44. PubMed ID: 525150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis of experimental rabies with the polyriboinosinic-polyribocytidylic acid complex.
    Fenje P; Postic B
    J Infect Dis; 1971 Apr; 123(4):426-8. PubMed ID: 5110740
    [No Abstract]   [Full Text] [Related]  

  • 35. Production of human lymphoblastoid (Namalva) interferon.
    Mizrahi A
    Methods Enzymol; 1981; 78(Pt A):54-68. PubMed ID: 6173640
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of interferon messenger RNA from human lymphoblastoid cells.
    Morser J; Flint J; Meager A; Graves H; Baker PN; Colman A; Burke DC
    J Gen Virol; 1979 Jul; 44(1):231-4. PubMed ID: 227993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A semi-continuous system for the production of human interferon in lymphoblastoid cell cultures.
    De Ley M; Billiau A; De Somer P
    J Gen Virol; 1978 Aug; 40(2):455-8. PubMed ID: 690609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabies in rabbits and mice: protective effect of polyriboinosinic-polyribocytidylic acid.
    Janis B; Habel K
    J Infect Dis; 1972 Apr; 125(4):345-52. PubMed ID: 4553077
    [No Abstract]   [Full Text] [Related]  

  • 40. Different mechanisms for alpha and beta interferon induction.
    Lebon P; Commoy-Chevalier MJ; Robert-Galliot B; Chany C
    Virology; 1982 Jun; 119(2):504-7. PubMed ID: 6177097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.